Current through Register Vol. XLI, No. 50, December 13, 2024
Section 69-11-33 - Medical Withdrawal33.1. Medical withdrawal occurs as a voluntary and therapeutic withdrawal agreed upon by clinical staff and the patient in accordance with approved national guidelines including, but not limited to, ASAM, CSAT, NIDA, AATOD, FSMB and SAMHSA. In some cases, the withdrawal may be against the advice of clinical staff or against medical advice.33.2. The MAT program shall supply a schedule of dose reduction well tolerated by the patient.33.3. The program shall offer supportive treatment, including increased counseling sessions and referral to a self-help group or other counseling provider as appropriate.33.4. If the patient leaves the MAT program abruptly against medical advice, the program may readmit the patient within 30 days without a formal reassessment procedure. However, the program must perform a physical assessment and a biopsychosocial assessment upon readmission. The program shall document attempting to assist the patient with any issues which may have triggered his or her abrupt departure.33.5. The MAT program shall make provisions for continuing care for each patient following the last dose of medication and for re-entry to maintenance treatment if relapse occurs or if the patient should reconsider withdrawal.33.6. Female patients shall have a negative pregnancy screen prior to the onset of medically-supervised withdrawal.33.7. The program shall have in place a detailed relapse prevention plan developed by the primary counselor in accordance with approved national guidelines and in conjunction with the patient. The prevention plan shall be given to the patient in writing prior to the administration of the final dose of medication.W. Va. Code R. § 69-11-33